Autumn Glory Partners’s Sanofi SNY Stock Holding History

Autumn Glory Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,300	Closed	-$209K	–	178
2024 Q1	$209K	Hold	4,300	–	–	0.1%	158
2023 Q4	$222K	Hold	4,300	–	–	0.13%	151
2023 Q3	$231K	Hold	4,300	–	–	0.14%	139
2023 Q2	$232K	Sell	4,300 -4,300	-50%	-$231K	0.17%	124
2023 Q1	$468K	Hold	8,600	–	–	0.4%	65
2022 Q4	$416K	Buy	+8,600	New	+$377K	0.22%	120
2022 Q3	–	Sell	-4,300	Closed	-$215K	–	169
2022 Q2	$215K	Sell	4,300 -4,300	-50%	-$228K	0.16%	137
2022 Q1	$442K	Buy	8,600 +3,038	+55%	+$157K	0.26%	106
2021 Q4	$278K	Buy	+5,562	New	+$275K	0.12%	168

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Autumn Glory Partners's SNY Position: Q2 2024 in Review

Autumn Glory Partners sold out of Sanofi (SNY) in Q2 2024, closing a stake of 4,300 shares — an estimated $209K sold.

Autumn Glory Partners first reported a position in SNY in Q4 2021 and held it in 9 quarters. The position peaked at $468K in Q1 2023. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2024.

Autumn Glory Partners reported no remaining Sanofi position as of Q2 2024 after selling out during the quarter.
Autumn Glory Partners sold 4,300 Sanofi shares in Q2 2024, an estimated $209K.
Autumn Glory Partners first reported a position in Sanofi in Q4 2021 and held it in 9 quarters.
Autumn Glory Partners's Sanofi position peaked at $468K in Q1 2023.
730 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.

Based on Autumn Glory Partners's 13F filing for Q2 2024, filed 1 Aug 2024.